Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
Original Research | By T Chakravarty, A Patel, S Kapadia et al.
BACKGROUND- There is paucity of evidence on the impact of anticoagulation (AC) after bioprosthetic aortic valve replacement (AVR) on valve hemodynamics and clinical outcomes. OBJECTIVES- The study aimed to assess the impact of AC after bioprosthetic AVR on valve hemodynamics and clinical outcomes. METHODS- Data on antiplatelet and antithrombotic therapy were collected. E...
Original Research | By McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators.
Infective endocarditis after transcatheter aortic valve implantation: a nationwide study
Original Research | By Bjursten H, Rasmussen M, Nozohoor S et al.
AIMS - Transcatheter aortic valve implantation (TAVI), now a common procedure to treat high-risk patients with severe aortic stenosis, has rapidly been expanding into younger and lower-risk populations, creating a need to better understand long-term outcome after TAVI. The aim of the present investigation was to determine the incidence, risk factors for, clinical presentation of, and outcome after prosthetic valve endocarditis (PVE)...
Original Research | By H Jilaihawi, ZG Zhao, R Du et al.
OBJECTIVES - This study sought to minimize the risk of permanent pacemaker implantation (PPMI) with contemporary repositionable self-expanding transcatheter aortic valve replacement (TAVR). BACKGROUND- Self-expanding TAVR traditionally carries a high risk of PPMI. Limited data exist on the use of the repositionable devices to minimize this risk. METHODS- At NYU...
Guideline | By SV Konstantinides, G Meyer, ESC Scientific Document Group
Guideline | By F Cosentino, PJ Grant, ESC Scientific Document Group et al.
Guideline | By J Knuuti, W Wijns, ESC Scientific Document Group et al.
Guideline | By F Mach, C Baigent, ESC Scientific Document Group et al.
Guideline | By J Brugada, DG Katritsis, ESC Scientific Document Group et al.